These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 16969036)

  • 1. [A patient with pancreatic cancer and multiple liver metastases after total pancreatectomy who showed a partial response to combination chemotherapy with gemcitabine and UFT].
    Machida H; Ushida S; Suzuki K; Toda H
    Gan To Kagaku Ryoho; 2006 Sep; 33(9):1333-5. PubMed ID: 16969036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of recurrent pancreatic cancer responding to TS-1 combined gemcitabine chemotherapy after UFT combined gemcitabine chemotherapy resulting progressive disease].
    Sunagozaka H; Yamashita T; Kagaya T; Kato Y; Kaneko S
    Gan To Kagaku Ryoho; 2006 Jun; 33(6):829-32. PubMed ID: 16770107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of successful management of nonresectable pancreas cancer with liver metastasis by intra-arterial infusion chemotherapy with gemcitabine hydrochloride, 5-FU, CDDP and administration of tegafur/uracil].
    Ishikawa T; Mizuno K; Watanabe K; Baba Y; Oota H; Yoshida T; Kamimura T
    Gan To Kagaku Ryoho; 2004 Oct; 31(10):1555-8. PubMed ID: 15508450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of metastatic pancreatic cancer after combination chemotherapy with uracil-tegafur and gemcitabine].
    Sugimoto K; Okada K; Nakahira S; Okamura S; Miki H; Nakata K; Suzuki R; Yoshimura M; Uji K; Yoshida A; Tamura S
    Gan To Kagaku Ryoho; 2009 Feb; 36(2):321-3. PubMed ID: 19223756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II study of gemcitabine combined with uracil-tegafur in metastatic pancreatic cancer.
    Lee J; Park JO; Kim WS; Lee SI; Song SY; Lim DH; Choi SH; Heo JS; Lee KT; Lee JK; Kim K; Jung CW; Im YH; Lee MH; Kang WK; Park K
    Oncology; 2004; 66(1):32-7. PubMed ID: 15031596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II study on low dose gemcitabine plus oral chemotherapy with uracil-tegafur and cyclophosphamide in combination with radiotherapy against recurrent and advanced pancreatic cancer.
    Nio Y; Hashimoto K; Yano S; Itakura M; Koike M; Yamaguchi K; Endo S; Tsuji M; Higami T; Maruyama R
    Oncol Rep; 2005 Aug; 14(2):401-8. PubMed ID: 16012722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A resected case of effective treatment with S-1/gemcitabine and Paclitaxel combination chemotherapy for advanced pancreatic cancer with peritoneal and liver metastases].
    Kimura H; Fushida S; Mukawa A
    Gan To Kagaku Ryoho; 2009 Jul; 36(7):1191-4. PubMed ID: 19620816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of complete response of gemcitabine (GEM) monotherapy-refractive liver metastatic pancreatic cancer treated with GEM+S-1 combined chemotherapy].
    Hatata T; Takaya S; Taniguchi K; Naka T; Kondo A; Ikeguchi M
    Gan To Kagaku Ryoho; 2011 Jan; 38(1):109-12. PubMed ID: 21368469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical benefit of full-dose gemcitabine for advanced pancreatic cancer refractory to S-1+gemcitabine].
    Hachisuka H; Takahashi M; Kushima A; Nakamoto T; Takahashi K; Iwamura Y; Wakata M; Nagano K; Nakajima T; Nunomura M; Araki K
    Gan To Kagaku Ryoho; 2013 May; 40(5):639-42. PubMed ID: 23863590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Local recurrence after surgical resection of pancreatic cancer effectively treated with combined chemoradiotherapy].
    Obuchi T; Sasaki A; Shimooki O; Minakawa Y; Abe T; Nitta H; Otsuka K; Koeda K; Ikeda K; Wakabayashi G
    Gan To Kagaku Ryoho; 2009 Jun; 36(6):991-4. PubMed ID: 19542722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Phase I study of gemcitabine (GEM) and UFT combination chemotherapy for unresectable/recurrent pancreatic cancer].
    Nakamori S; Tujie M; Takahashi Y; Maruhashi S; Miyamoto A; Nagano H; Dono K; Umeshita K; Sakon M; Monden M
    Gan To Kagaku Ryoho; 2004 Jan; 31(1):51-4. PubMed ID: 14750321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Schedule-dependent therapeutic effects of gemcitabine combined with uracil-tegafur in a human pancreatic cancer xenograft model.
    Tsujie M; Nakamori S; Nakahira S; Takeda S; Takahashi Y; Hayashi N; Okami J; Nagano H; Dono K; Umeshita K; Sakon M; Monden M
    Pancreas; 2006 Aug; 33(2):142-7. PubMed ID: 16868479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effective multidisciplinary therapy mainly using S-1+ gemcitabine (GEM) for a case of pancreatic body cancer with multiple liver metastases].
    Fukui H; Kou C; Fujioka M
    Gan To Kagaku Ryoho; 2012 Nov; 39(11):1727-31. PubMed ID: 23152029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of multiple hepatic metastases of gastric cancer that showed complete regression by systemic chemotherapy using paclitaxel and UFT-E].
    Okamura H; Fujiwara H; Ichikawa D; Okamoto K; Kikuchi S; Kubota T; Ikoma H; Nakanishi M; Ochiai T; Sakakura C; Kokuba Y; Taniguchi H; Sonoyama T; Otsuji E
    Gan To Kagaku Ryoho; 2009 Jun; 36(6):987-90. PubMed ID: 19542721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of serum CA19-9 in patients with advanced pancreatic cancer receiving gemcitabine based chemotherapy.
    An X; Li YH; Lin XB; Wang FH; Feng F; Xu RH; Jiang WQ; He YJ
    Ai Zheng; 2009 Mar; 28(3):286-91. PubMed ID: 19619444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Multicenter phase II study of pre-administered uracil/tegafur (UFT) plus gemcitabine for unresectable/recurrent pancreatic cancer].
    Nakamori S; Endo W; Ozato H; Shibata T; Takeda Y; Tohno K; Hasuike Y; Masutani S; Morimoto T; Doki Y; Mori M; Monden M
    Gan To Kagaku Ryoho; 2011 May; 38(5):789-92. PubMed ID: 21566438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of pancreatic cancer with distant metastasis successfully resected after neoadjuvant chemotherapy with a combination of S-1 and gemcitabine].
    Maeda T; Tsuchiya M; Ishii J; Koda T; Kubota Y; Katagiri T; Tamura A; Otsuka Y; Shibuya K; Kaneko H
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):2184-6. PubMed ID: 25731464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility and efficacy of combination therapy with preoperative full-dose gemcitabine, concurrent three-dimensional conformal radiation, surgery, and postoperative liver perfusion chemotherapy for T3-pancreatic cancer.
    Ohigashi H; Ishikawa O; Eguchi H; Takahashi H; Gotoh K; Yamada T; Yano M; Nakaizumi A; Uehara H; Tomita Y; Nishiyama K
    Ann Surg; 2009 Jul; 250(1):88-95. PubMed ID: 19561477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Two Cases of Liver Metastasis from Pancreatic Cancer with a Complete Response Owing to Chemotherapy].
    Suda H; Omori K; Suematsu Y; Hiratsuka M; Takahashi M; Saito H; Ishibashi Y; Morita A; Wakabayashi K; Ito Y
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):2388-90. PubMed ID: 26805373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of effective treatment with S-1/gemcitabine chemotherapy and resection for advanced pancreatic cancer with peritoneal dissemination].
    Koga H; Miyoshi A; Nakamura J; Ide T; Kitahara K; Noshiro H
    Gan To Kagaku Ryoho; 2014 May; 41(5):665-8. PubMed ID: 24917019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.